Effects of sparfloxacin, grepafloxacin, moxifloxacin, and ciprofloxacin oncardiac action potential duration

Citation
L. Patmore et al., Effects of sparfloxacin, grepafloxacin, moxifloxacin, and ciprofloxacin oncardiac action potential duration, EUR J PHARM, 406(3), 2000, pp. 449-452
Citations number
19
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
406
Issue
3
Year of publication
2000
Pages
449 - 452
Database
ISI
SICI code
0014-2999(20001020)406:3<449:EOSGMA>2.0.ZU;2-O
Abstract
Fluoroquinolone antibiotics have been associated with QT prolongation follo wing administration to humans. This study compares the effects of four fluo roquinolones, sparfloxacin, grepafloxacin, moxifloxacin and ciprofloxacin e naction potential duration recorded from canine isolated cardiac Purkinje f ibres. Left and right ventricular Purkinje fibres were isolated from canine hearts and continuously superfused with physiological salt solution. Actio n potential duration at 90% repolarization was recorded via intracellular m icroelectrodes. Sparfloxacin, grepafloxacin, moxifloxacin and ciprofloxacin prolonged action potential duration in a concentration dependent manner. M ean concentrations causing a 15% prolongation of action potential duration recorded at a stimulation frequency of 1 Hz were: sparfloxacin 4.2 +/- 0.7 mug/ml; grepafloxacin 9.3 +/- 0.9 mug/ml; moxifloxacin 9.9 +/- 1.6 mug/ml a nd ciprofloxacin 72.8 +/- 26.4 mug/ml. Prolongation was inverse frequency d ependent with larger increases in action potential duration occurring when the stimulation frequency was reduced to 0.5 Hz. These results indicate tha t effects on action potential duration vary within this class of compound. Rank order of potency was sparfloxacin > grepafloxacin = moxifloxacin > cip rofloxacin. (C) 2000 Elsevier Science B.V. All rights reserved.